Anti-IgA
Test Summary
For the evaluation of patients with recurrent infection for the possibility of IgA deficiency (IgAD). Patients with IgA deficiency may develop antibodies against IgA that make them susceptible to adverse reactions to blood products including intravenous immunoglobulin.
Aliases
- Viracor code 2107
Specimen Collection
Special Instructions
N/A
Preferred Specimen
1 mL serum
Minimum Volume
0.1 mL
Instructions
N/A
Patient Preparation
N/A
Storage
Plastic screw-cap vial
Transport Temperature
Room Temperature
Specimen Stability
- Room Temperature: 7 Days
- Refrigerated: 7 Days
- Frozen: 14 Days
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
N/A
Order Code
AAIGA
EPIC (Premier) Code
LAB6039
Includes
N/A
CPT Code
- 83520
Billing Code
- 700000
CPT Statement
Methodology
ELISA using human polyclonal IgA coupled to the solid phase
FDA Status
This test was developed and its performance characteristics have been determined by Eurofins Viracor. It has not been cleared or approved by the U.S. Food and Drug Administration.
Physician Attestation of Informed Consent
N/A
Testing Laboratory
VIRACOR EUROFINS CLINICAL DIAGNOSTICS
1001 NW TECHNOLOGY DR
Lee's Summit MO, 64086
1001 NW TECHNOLOGY DR
Lee's Summit MO, 64086
Reference Range
N/A
Setup Schedule / Expected Turnaround Time
Report available: 5 - 8 business days
Specimen Collection
Special Instructions
N/A
Preferred Specimen
1 mL serum
Minimum Volume
0.1 mL
Instructions
N/A
Patient Preparation
N/A
Storage
Plastic screw-cap vial
Transport Temperature
Room Temperature
Specimen Stability
- Room Temperature: 7 Days
- Refrigerated: 7 Days
- Frozen: 14 Days
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
N/A
Result Information
Methodology
ELISA using human polyclonal IgA coupled to the solid phase
Testing Laboratory
N/A
Reference Range
N/A
Setup Schedule / Expected Turnaround Time
Report available: 5 - 8 business days